Australia's Orthocell rises after new product used in US surgery

Orthocell

27/06/2025 03:24

** Orthocell OCC.AX stock up 3.72% to A$1.235

** Earlier, stock rose as much as 9.5% to A$1.325, its highest level since June 6

** Regenerative medicine maker records first use of Remplir, its nerve repair device, in a surgery in the US

** YTD, stock down 7.38%

 (Reporting by Shruti Agarwal in Bengaluru)

 ((Shruti.Agarwal@thomsonreuters.com))